Senior Director, Financial Planning and Analysis

Vera Therapeutics (Nasdaq: VERA), is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera’s mission is to advance treatments that target the source of immunologic diseases in order to change the standard of care for patients. Vera’s lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy. Vera is also evaluating the role of atacicept in other immunologic disorders. Additionally, Vera is developing VT-109, a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development, and MAU868, a monoclonal antibody designed to neutralize infection with BK virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplant.

Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do—from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases.

Position Summary The Senior Director of Financial Planning & Analysis (FP&A) will report to the Vice President, FP&A and serve as the finance business partner to the Chief Medical Officer and Chief Business Officer’s organizations. In this hands‑on role, this leader will deliver best-in-class FP&A partnership to the business and support Vera’s first product launch in rare kidney disease. The role will be a manager of a small team supporting the Chief Medical Officer and Chief Business Officer’s organizations. Business partner assignments may evolve over time.

Responsibilities

Partner with each executive leader in areas of responsibility, and their teams, to ensure financial considerations are incorporated in business decisions.

Deliver insightful and timely management reporting at the functional and executive levels. Develop fit‑for‑purpose financial analytics for areas of responsibility to enhance transparency and decision‑making.

Lead strategic planning processes (e.g. budget, forecast, long range plan) for areas of responsibility. Identify strategic opportunities and challenges.

Drive additional rigor in R&D investments, and adoption of program‑level reporting and planning - including clinical trial costs.

Develop concise and insightful presentations with conclusions and recommendations for functional and executive management.

Analyze productivity drivers, identify risks and opportunities to business performance, work cross‑functionally to implement recommended actions.

Ensure close collaboration with accounting and other teams to ensure alignment of actual results and forecasts and to support month‑end close and financial reporting.

Perform ad hoc analyses and special projects as needed.

Hire, coach, and develop FP&A talent.

Promote a culture of high engagement, high performance, and continuous improvement that values learning and a commitment to quality.

Qualifications

Bachelor’s degree required, MBA preferred.

12+ years’ experience in biopharmaceuticals finance/FP&A with progressive leadership growth, including 3+ years of managerial experience.

Highly effective written and oral communication skills, including distilling complexities into key takeaways, delivering clear and compelling presentations, and demonstrating executive presence.

Experience supporting R&D, global program teams, and product launches.

Experience with forecasting clinical trial costs (i.e. organically, and using tools such as Auxilius)

Extensive experience analyzing data across financial and operational systems to derive meaningful business insights.

Extensive experience with Excel and PowerPoint, ERPs (e.g. Netsuite), and financial planning systems (e.g. Adaptive).

Continuous improvement mindset.

Working knowledge of GAAP.

Attention to detail with ability to move easily between hands‑on work and strategic thinking.

Ability to multitask and prioritize.

Equal Opportunity Statement Vera Therapeutics Inc. is an equal‑opportunity employer.

Compensation Vera Therapeutics is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

For this role, the anticipated base pay range is

$250,000 - $290,000 USD

#J-18808-Ljbffr